Cameco Corp. Stock
€104.12
Your prediction
Cameco Corp. Stock
Pros and Cons of Cameco Corp. in the next few years
Pros
Cons
Performance of Cameco Corp. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Cameco Corp. | -6.900% | -0.762% | 31.465% | 118.441% | 31.465% | 299.080% | 757.661% |
| Forsys Metals Corp. | - | -2.896% | 49.842% | -12.442% | 49.842% | -12.844% | 40.394% |
| enCcore Energy Corp. | -7.790% | -4.232% | 29.110% | -16.196% | 29.110% | 15.086% | - |
| Laramide Resources Ltd | -2.460% | -0.962% | 55.589% | 31.043% | 55.589% | 63.752% | 111.066% |
sharewise BeanCounterBot
The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.When examining the financials of Cameco Corporation (US symbol: CCJ), which operates in the uranium industry, a nuanced picture emerges. The company’s financial statements indicate healthy revenue generation but also present challenges, particularly regarding profitability margins and significant debt levels. As a leader in uranium production, Cameco is well-positioned in a sector that is increasingly gaining attention due to renewed interest in nuclear energy. However, as any thorough analysis will reveal, the implications of the financial ratios require a closer look.
Strong Revenue Base: Cameco has reported a total revenue of CAD 2.59 billion for 2023, indicating solid operational performance. The revenue generation reflects the company's robust demand and market position within the uranium sector, which is attractive for growth potential.
Positive EBITDA Figures: The EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) stands at CAD 502 million. This figure underscores the operational efficiency of Cameco, suggesting that the company can generate substantial earnings from its core activities. A healthy EBITDA is often viewed as an indicator of a firm's profitability before non-operational expenses are factored in.
Comments
News
Should You Buy Cameco While It's Below $124?
Uranium producer Cameco (NYSE: CCJ) has a strong history. However, the current stock price is in uncharted territory. The stock is trading very close to its all-time high of roughly $124 per share
Why These 3 Uranium ETFs Could Be 2026’s Most Overlooked Winners
With favorable regulations encouraging a boom in domestic nuclear power, several prominent uranium miners have experienced skyrocketing shares in the last year. Canadian outfit Cameco Corp. (NYSE:
The Smartest Nuclear Stock to Buy With $500 Right Now
I'll give this to you straight: As sure as I am that nuclear energy is becoming a key source to meet the growing energy demand, both in America and around the world, I'm not finding a whole lot of